Reported Mammographic Density: Film-Screen versus Digital Acquisition

Reported Mammographic Density: Film-Screen versus Digital Acquisition
 
Jennifer A. Harvey, Charlotte C. Gard, Diana L. Miglioretti, Bonnie C. Yankaskas, Karla Kerlikowske, Diana S. M. Buist, Berta A. Geller, Tracy L. Onega, and For the Breast Cancer Surveillance Consortium

Radiology 2013;266 752-758

Click for abstract

Because the results of this study showed that Breast Imaging Reporting and Data System (BI-RADS) breast density categories reported do not differ according to acquisition method, these density categories could be used in the development of breast cancer risk models in which both film-screen and digital mammography are used.

sic; thererefore, related breast density studies associated with breast cancer risk likely apply regardless of whether you have had a digital mammogram or older analog exam.

Related articles

• Moffitt Cancer Center researchers develop automated breast density test linked to cancer risk

Bilateral Contrast-enhanced Dual-Energy Digital Mammography in women with known breast cancer

Bilateral Contrast-enhanced Dual-Energy Digital Mammography: Feasibility and Comparison with Conventional Digital Mammography and MR Imaging in Women with Known Breast Carcinoma

Maxine S. Jochelson, D. David Dershaw, Janice S. Sung, Alexandra S. Heerdt, Cynthia Thornton, Chaya S. Moskowitz, Jessica Ferrara, and Elizabeth A. Morris
Radiology 2013;266 743-751

Contrast enhanced dual energy mammography in women with known breast cancer
 

Bilateral dual-energy contrast-enhanced digital mammography was feasible, easily accomplished, and depicted known primary tumors at a rate comparable to that of MR imaging and higher than that of conventional digital mammography.

Tumor Angiogenesis Change Estimated by Using Diffuse Optical Spectroscopic Tomography: Demonstrated Correlation in Women Undergoing Neoadjuvant Chemotherapy for Invasive Breast Cancer?

Tumor Angiogenesis Change Estimated by Using Diffuse Optical Spectroscopic Tomography: Demonstrated Correlation in Women Undergoing Neoadjuvant Chemotherapy for Invasive Breast Cancer?
Marius G. Pakalniskis, Wendy A. Wells, Mary C. Schwab, Heather M. Froehlich, Shudong Jiang, Zhongze Li, Tor D. Tosteson, Steven P. Poplack, Peter A. Kaufman, Brian W. Pogue, and Keith D. Paulsen
Radiology 2011; 259 365-374

Link to Journal

This study results show a correlation between changes in total tissue hemoglobin at diffuse optical spectroscopic tomography and tumor angiogenesis and demonstrate how this noninvasive modality might allow individualization and optimization of neoadjuvant chemotherapy regimens.

Evaluation of Clinical Breast MR Imaging Performed with Prototype Computer-aided Diagnosis Breast MR Imaging Workstation: Reader Study

Evaluation of Clinical Breast MR Imaging Performed with Prototype Computer-aided Diagnosis Breast MR Imaging Workstation: Reader Study
Akiko Shimauchi, Maryellen L. Giger, Neha Bhooshan, Li Lan, Lorenzo L. Pesce, John K. Lee, Hiroyuki Abe, and Gillian M. Newstead
Radiology 2011; 258 696-704

Link to Journal

Use of a diagnostic computer aid for dynamic contrast-enhanced MR imaging has the potential to improve radiologists' performance in differentiating between benign and malignant breast lesions

The Mammographic Density of a Mass Is a Significant Predictor of Breast Cancer

The Mammographic Density of a Mass Is a Significant Predictor of Breast Cancer
Ryan W. Woods, Gale S. Sisney, Lonie R. Salkowski, Kazuhiko Shinki, Yunzhi Lin, and Elizabeth S. Burnside
Radiology 2011; 258 417-425

Link to Journal

Our study shows that, in contrast to previous research, breast mass density is significantly associated with malignancy, even after controlling for other predictive variables

Breast Cancer: Early and Late Fluorescence Near-Infrared Imaging with Indocyanine Green: A Preliminary Study

Breast Cancer: Early and Late Fluorescence Near-Infrared Imaging with Indocyanine Green: A Preliminary Study
Alexander Poellinger, Susen Burock, Dirk Grosenick, Axel Hagen, Lutz Ludemann, Felix Diekmann, Florian Engelken, Rainer Macdonald, Herbert Rinneberg, and Peter-Michael Schlag
Radiology 2011; 258 409-416

Link to Journal

By capitalizing on the extravasation of indocyanine green (ICG) through the wall of tumorous vessels and consequently using late-fluorescence mammograms, we were able to achieve far more pronounced contrast between the tumorous and healthy background tissue (mean contrast value, 0.64) compared with this contrast on images acquired during or shortly after the administration of ICG (mean contrast value, 0.25)

Multicenter, Double-Blind, Randomized, Intraindividual Crossover Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for Breast MR Imaging (DETECT Trial)

Multicenter, Double-Blind, Randomized, Intraindividual Crossover Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for Breast MR Imaging (DETECT Trial)
Laura Martincich, Matthieu Faivre-Pierret, Christian M. Zechmann, Stefano Corcione, Harrie C. M. van den Bosch, Wei-Jun Peng, Antonella Petrillo, Katja C. Siegmann, Johannes T. Heverhagen, Pietro Panizza, Hans-Bjorn Gehl, Felix Diekmann, Federica Pediconi, Lin Ma, Fiona J. Gilbert, Francesco Sardanelli, Paolo Belli, Marco Salvatore, Karl-Friedrich Kreitner, Claudia M. Weiss, and Chiara Zuiani
Radiology 2011; 258 396-408

Link to Journal

Gadobenate dimeglumine (0.1 mmol/kg) results in significantly (P [≤ ] . 0003) greater breast cancer detection rate and significantly (P [≤ ] . 0094) better diagnostic performance relative to that achieved with gadopentetate dimeglumine at an equivalent dose